Cmps stock forecast.

COMPASS Pathways. Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies, and are pioneering ...

Cmps stock forecast. Things To Know About Cmps stock forecast.

Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Genco Shipping & Trading Ltd have a median target of 19.80, with a high estimate of 27.00 and a low estimate of 15.00 ...SQ Sales Forecast. Next quarter’s sales forecast for SQ is $5.60B with a range of $5.01B to $5.87B. The previous quarter’s sales results were $5.62B. SQ beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 65.18% of the time in the same period.Real time Compass Pathways Plc (CMPS) stock price quote, stock graph, news & analysis.LPTX Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Leap Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $12.00 and a low forecast of $7.00. The average price target represents a 249.65% change from the last price of $2.86.

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression, and launches new research center. Read more. Compass is a biotechnology company dedicated to accelerating patient access and experience to evidence-based innovation in mental health care.ANET Stock 12 Months Forecast. $216.73. (2.00% Upside) Based on 16 Wall Street analysts offering 12 month price targets for Arista Networks in the last 3 months. The average price target is $216.73 with a high forecast of $232.00 and a low forecast of $190.00. The average price target represents a 2.00% change from the last price of …

3 brokers have issued twelve-month price targets for eXp World's shares. Their EXPI share price targets range from $14.00 to $28.00. On average, they anticipate the company's share price to reach $21.00 in the next year. This suggests a possible upside of 70.9% from the stock's current price. View analysts price targets for EXPI or view top ...Jul 1, 2023 · While Compass Pathways' (CMPS 0.84%) stock is near $8, the analysts on Wall Street are figuring, on average, that its shares will explode by 458% to reach around $42.30 within the next 12 months.

GGB Earnings Forecast. Next quarter’s earnings estimate for GGB is $0.17 with a range of $0.14 to $0.20. The previous quarter’s EPS was $0.19. GGB beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.34% of the time in the same period.A high-level overview of COMPASS Pathways plc (CMPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, ... Wall Street’s 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS)Detailed statistics for COMPASS Pathways plc (CMPS) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast. The ...

Nov 29, 2023 · Analyst Forecast. According to 5 analysts, the average rating for CMPS stock is "Strong Buy." The 12-month stock price forecast is $49.6, which is an increase of 736.43% from the latest price.

See the latest Compass Pathways PLC ADR stock price (CMPS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

V Stock 12 Months Forecast. $276.95. (8.91% Upside) Based on 23 Wall Street analysts offering 12 month price targets for Visa in the last 3 months. The average price target is $276.95 with a high forecast of $295.00 and a low forecast of $243.00. The average price target represents a 8.91% change from the last price of $254.30.COMPASS Pathways PLC ADR (CMPS) Company Bio. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and ...COMPASS Pathways. Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies, and are pioneering ...A high-level overview of COMPASS Pathways plc (CMPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find the latest Cybin Inc. (CYBN) stock quote, history, news and other vital information to help you with your stock trading and investing.

In the last 3 months, 5 analysts have offered 12-month price targets for Compass Pathways. The company has an average price target of $50.6 with a high of $120.00 and a low of $19.00. Below is a ...According to COMPASS Pathways's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.54468. At the end of 2022 ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ... According to . 4 Wall Street analysts that have issued a 1 year CMPS price target, the average CMPS price target is $57.25, with the highest CMPS stock price forecast at $120.00 and the lowest CMPS stock price forecast at $21.00.See the latest Compass Pathways PLC ADR stock price (CMPS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.(See CMPS stock forecast on TipRanks) Wallbox N.V. The next stock on analysts' radar is Wallbox, a company that provides solutions for EV charging that are adaptable to customer needs.

Gilead Sciences Inc Stock Forecast, Predictions & Price Target. Add to Watchlist. Overview Forecast. Earnings Dividend Ownership. Analyst price target for GILD. All Analysts Top Analysts. Based on 9 analysts offering 12 month price targets for Gilead Sciences Inc. Min Forecast. $71.00-5.23%. Avg Forecast.

BIOR Stock 12 Months Forecast. $50.00. (3603.70% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Biora Therapeutics in the last 3 months. The average price target is $50.00 with a high forecast of $50.00 and a low forecast of $50.00. The average price target represents a 3603.70% change from the last price of $1.35.Discover historical prices for CMPS stock on Yahoo Finance. View daily, weekly or monthly format back to when COMPASS Pathways plc stock was issued. Compass Pathways Plc - ADR Stock Price Forecast, "CMPS" Predictons for2023In the last 3 months, 5 analysts have offered 12-month price targets for Compass Pathways. The company has an average price target of $50.6 with a high of $120.00 and a low of $19.00. Below is a ...COMP360 Overview (August Company Presentation) Psilocybin is a hallucinogenic chemical found in psychedelic mushrooms. It also is in Phase II clinical trials for the treatment of post-traumatic ...Future criteria checks 0/6. COMPASS Pathways's earnings are forecast to decline at 2.7% per annum while its annual revenue is expected to grow at 82.4% per year. EPS is expected to grow by 6.1% per annum. Return on equity is forecast to be -82.5% in 3 years.Toyota Motor Stock Forecast FAQ. What is TM's revenue growth forecast for 2024-2026? ... On average, 1 Wall Street analysts forecast TM's revenue for 2025 to be $3,829,246,010,307,400, with the lowest TM revenue forecast at $3,829,246,010,307,400, and the highest TM revenue forecast at $3,829,246,010,307,400.Oct 30, 2023 · Nikkei 225. 30,696.96. -0.95%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Compass Pathways PLC (CMPS.OQ) real-time stock quotes, news, price and financial information from ... Find real-time FUBO - Fubotv Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.33: Annual revenue (last year) $1.0B: Annual profit (last year)COMPASS Pathways PLC Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong …

Price target. 52.60 0.00 0.00%. The 5 analysts offering 1 year price forecasts for CMPS have a max estimate of — and a min estimate of —.

The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...

LHX Stock 12 Months Forecast. Based on 15 Wall Street analysts offering 12 month price targets for L3Harris Technologies in the last 3 months. The average price target is $207.86 with a high forecast of $230.00 and a low forecast of $162.00. The average price target represents a 11.51% change from the last price of $186.40.Real time Compass Pathways Plc (CMPS) stock price quote, stock graph, news & analysis. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Flora Growth Corp have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median ...Jul 2, 2023 · CMPS Stock Forecast. TradingView. CMPS is trading in a sideways channel between $7.67 and $11.17 and will likely continue to trade in this channel until a strong catalyst pushes it out. Barring ... Find real-time INMD - Inmode Ltd stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.77: Annual revenue (last year) $454.3M: Annual profit (last ...Current. -$0.61. 1 Month Ago. -$0.60. 3 Months Ago. -$0.65. COMPASS Pathways PLC ADR analyst estimates, including CMPS earnings per share estimates and analyst recommendations.AURA. Aura Biosciences Inc. 8.03. UNCH. UNCH. Get Compass Pathways PLC (CMPS:NASDAQ) real-time stock quotes, news, price and financial information from …The head of COMPASS Pathways (CMPS) contended that investors should keep in mind the positive results displayed in a recent clinical trial of its psychedelics-based treatment for depression.According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,105.36% from the latest price. Price Target. $13.5 (1,105.36% upside) Analyst Consensus: Strong Buy. Stock Forecasts. ... Other symbols: CMPS CYBN MNMD.COMPASS Pathways Stock Forecast All Analysts Top Analysts Stock Price Forecast According to 5 stock analysts, the average 12-month stock price forecast for …According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy. Analyst Consensus: Strong Buy. Target Low Average Median High; Price: $116: $170.76: …PLAN Stock 12 Months Forecast. $65.10. (2.15% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Anaplan in the last 3 months. The average price target is $65.10 with a high forecast of $66.00 and a low forecast of $63.75. The average price target represents a 2.15% change from the last price of $63.73.

Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. THRX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Theseus Pharmaceuticals in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 278.95% change from the last price of $2.38.Nov 29, 2023 · The company has $148.49 million in cash and $32.84 million in debt, giving a net cash position of $115.65 million or $1.87 per share. Cash & Cash Equivalents. Instagram:https://instagram. wandt offshore stockonecxvanguard realestatebest stock alert service Compass Pathways stock indicated to open around $25.00, or 47% above the $17 IPO price. Sep. 18, 2020 at 10:17 a.m. ET by Tomi Kilgore. Market Activity. Funds + ETFs. Analyst ratings can be used in addition to other personal research work prior to making investment decisions. Do Not Sell My Personal Information (CA Residents Only ... fry's investment reporttqqqm The company has $248.37 million in cash and $32.53 million in debt, giving a net cash position of $215.84 million or $3.49 per share. Cash & Cash Equivalents. day trader software Iovance Biotherapeutics Inc Stock Forecast, Predictions & Price Target. Add to Watchlist. Overview Forecast. Earnings Dividend Ownership. Analyst price target for IOVA. All Analysts Top Analysts. Based on 9 analysts offering 12 month price targets for Iovance Biotherapeutics Inc. Min Forecast. $12.00 +117%. Avg Forecast.Innoviz Technologies Ltd. (NASDAQ:INVZ) announced its earnings results on Wednesday, November, 8th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.01. The firm earned $3.48 million during the quarter, compared to the consensus estimate of $3.08 million.